Aurora Cannabis, CanniMed Gains Momentum with Pharma LOI


April 5, 2018: Aurora Cannabis Inc. (TSX:ACB) and CanniMed Therapeutics Inc. (TSX:CMED) announced on Wednesday that CanniMed has signed letter of intent (LOI) to become a preferred supplier of medical cannabis to Pharmasave, one of Canada’s leading independent community pharmacies with more than 650 stores across the country. Aurora Cannabis is close to acquiring all the issued and outstanding common shares of CanniMed Therapeutics following its previously-announced acquisition. Pursuant to regulatory changes that would allow such distribution, CanniMed and Aurora will supply and distribute high-quality medical cannabis, produced at the companies’ facilities that are GMP compliant and GMP certified, via Pharmasave pharmacists across the Canadian region. Furthermore, CanniMed and Aurora Cannabis will provide education to pharmacists regarding medical cannabis. Aurora Cannabis, CanniMed Gains Momentum with Pharma LOI

thumbnail courtesy of


Please enter your comment!
Please enter your name here